Boost for Axplora’s antibody drug conjugate technology platform
The French National Agency for the Safety of Health Products (ANSM) has granted a pharmaceutical establishment license to Axplora’s Le Mans site.
Archives for December 15, 2022
Polyplus acquires Belgian and French CDMOs as firm sees hike in demand for higher quality raw materials and increased regulatory scrutiny
France’s Polyplus has made two acquisitions of late, one to expand its plasmid DNA engineering technology and services portfolio, and another to enhance its GMP fill and finish capacities.
Merck lines up agreement to advance development and manufacturing of viral vector based gene therapy applications in Japan
Merck has signed a Memorandum of Understanding (MoU) with Synplogen, a startup spun out of Kobe University's Graduate School of Science, Technology and Innovation.
Encouraging data from flu vaccine patch’s Phase 1 interim results
Vaxess Technologies has announced positive interim results for a first-in-human trial of its seasonal influenza vaccine patch.